- Home
- BBGI vs NRXP Comparison
BBGI vs NRXP Comparison
Compare BBGI & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBGI
- NRXP
- Stock Information
- Founded
- BBGI 1961
- NRXP 2015
- Country
- BBGI United States
- NRXP United States
- Employees
- BBGI N/A
- NRXP N/A
- Industry
- BBGI Broadcasting
- NRXP Biotechnology: Pharmaceutical Preparations
- Sector
- BBGI Consumer Discretionary
- NRXP Health Care
- Exchange
- BBGI Nasdaq
- NRXP Nasdaq
- Market Cap
- BBGI 13.2M
- NRXP 14.8M
- IPO Year
- BBGI 2000
- NRXP N/A
- Fundamental
- Price
- BBGI $8.46
- NRXP $1.16
- Analyst Decision
- BBGI
- NRXP Strong Buy
- Analyst Count
- BBGI 0
- NRXP 3
- Target Price
- BBGI N/A
- NRXP $31.33
- AVG Volume (30 Days)
- BBGI 6.7K
- NRXP 153.3K
- Earning Date
- BBGI 11-05-2024
- NRXP 11-18-2024
- Dividend Yield
- BBGI N/A
- NRXP N/A
- EPS Growth
- BBGI N/A
- NRXP N/A
- EPS
- BBGI 1.69
- NRXP N/A
- Revenue
- BBGI $238,754,777.00
- NRXP N/A
- Revenue This Year
- BBGI $2.55
- NRXP N/A
- Revenue Next Year
- BBGI N/A
- NRXP N/A
- P/E Ratio
- BBGI $4.88
- NRXP N/A
- Revenue Growth
- BBGI N/A
- NRXP N/A
- 52 Week Low
- BBGI $7.66
- NRXP $1.10
- 52 Week High
- BBGI $20.00
- NRXP $7.33
- Technical
- Relative Strength Index (RSI)
- BBGI 24.73
- NRXP 33.72
- Support Level
- BBGI $7.66
- NRXP $1.23
- Resistance Level
- BBGI $8.62
- NRXP $1.30
- Average True Range (ATR)
- BBGI 0.77
- NRXP 0.10
- MACD
- BBGI -0.52
- NRXP 0.00
- Stochastic Oscillator
- BBGI 8.78
- NRXP 12.12
About BBGI Beasley Broadcast Group Inc.
Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The Company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. The Company owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The Company currently operates three operating segments Audio, Digital and esports.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.